北大青鸟环宇(08095.HK)拟折让约19.35%配股 净筹最多6,727.2万元
北大青鸟环宇(08095.HK)公布,公司拟以每股0.5元配售最多1.36亿股新H股,较股份昨日(17日)於联交所收市价0.62元折让约19.35%。配售股份数目上限相当於公司於现有已发行H股总数及已发行股本总额之20%及约9.85%;及经扩大後已发行H股及已发行股本总额约16.67%及8.96%。
假设所有配售股份获配售,配售所得款项净额预期为约6,727.2万元,净发行价为每股配售股份约0.496元。公司拟将配售事项所得款项净额约80%用於潜在合并及收购及╱或发展新业务;及约20%用於集团之营运资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.